Li H, Luo YF, Blackwell TS, et al. Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections[J]. Antimicrob Agents Chemother, 2011, 55(12): 5900-5906.
Lee JY, Hwang SJ, Shim JW, et al. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia[J]. Diagnostic Immunology, 2010, 30(8): 406-413.
[6]
Esposito S, Tagliabue C, Picciolli I, et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia[J]. Respir Med, 2011, 105(12): 1939-1945.
[7]
Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections:the ProHOSP randomized controlled trial[J]. JAMA, 2009, 302(10): 1059-1066.
Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators[J]. Eur Respir J, 2007, 30(9): 556-573.
Li H, Luo YF, Blackwell TS, et al. Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections[J]. Antimicrob Agents Chemother, 2011, 55(12): 5900-5906.
Lee JY, Hwang SJ, Shim JW, et al. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia[J]. Diagnostic Immunology, 2010, 30(8): 406-413.
[6]
Esposito S, Tagliabue C, Picciolli I, et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia[J]. Respir Med, 2011, 105(12): 1939-1945.
[7]
Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections:the ProHOSP randomized controlled trial[J]. JAMA, 2009, 302(10): 1059-1066.
Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators[J]. Eur Respir J, 2007, 30(9): 556-573.
